Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score
David Albala, MD, Michael J. Kemeter, MSPAS, Phillip G. Febbo, MD, Ruixiao Lu, PhD, Vincy John, Dylan Stoy, Bela Denes, MD, Marybeth McCall, MD, Alan W. Shindel, MD, Frank Dubeck, MD
This analysis compares management patterns and costs from a baseline, untested population to a similar prospective, Genomic Prostate Score (GPS)-tested population. This unique study design allowed the authors to assess both the clinical utility and economic impact of using GPS in a real-world setting.
Perioperative Considerations in Metastatic Renal Cell Carcinoma
Kate Flavin, MRCP, FRCA, FFICM, Nikhil Vasdev, Jim Ashead, Tim Lane, Damian Hanbury, Paul Nathan, Shanmugasundaram Gowrie-Mohan
Patients with metastatic renal cell carcinoma are complex, with the potential for significant complications, and require extensive pre-, peri-, and postoperative management. This article discusses, in depth, the necessary considerations in the treatment of these patients.
Urology Group Compensation and Ancillary Service Models in an Era of Value-based Care
Neal D. Shore, MD, FACS, Dana Jacoby, MBA, MHS
Implementing new payment algorithms alongside comprehensive care coordination will assist urology groups in addressing the health economic cost and quality challenges that have been historically encountered with fee-for-service systems. Urology group leadership and stakeholders will need to adjust internal processes, methods of care coordination, cultural dependency, and organizational structures in order to create better systems of care and management. In response, ancillary services and patient throughput will need to evolve in order to adequately align quality measurement and reporting systems across provider footprints and patient populations.
Planning for Success
Celeste G. Kirschner, CAE
Georgia Urology, Atlanta, GA
Vahan Kassabian, MD, FACS, FRCS, Cynthia Masters, Jason Shelnutt, Chris Speaker, RT, CRLS
Laparoscopic Cystectomy Coding
Jonathan Rubenstein, MD
Highlights From the 2016 American Urological Association Annual Meeting,
May 6-10, 2016, San Diego, CA
Best of the 2016 AUA Annual Meeting
J. Curtis Nickel, MD, FRCSC, Michael A. Gorin, MD, Alan W. Partin, MD, PhD, Stacy Loeb, MD, MSc, Ellen Shapiro, MD, FACS, FAAP, Michael B. Chancellor, MD, Dean Assimos, MD, Michael Brawer, MD, Benjamin M. Brucker, MD
A Novel Approach to Mesh Revision After Sacrocolpopexy
Melissa L. Dawson, DO, MS, Rebecca Rinko, DO, Nima M. Shah, MD, Kristene E. Whitmore, MD
Reported herein are two cases of women with defecatory dysfunction and pain after sacrocolpopexy who underwent mesh revision procedures performed with both urogynecologic and colorectal surgery.
A Case of Pelvic Organ Prolapse in the Setting of Cirrhotic Ascites
Nima M. Shah, MD, Natasha Ginzburg, MD, Kristene Whitmore, MD
The authors present the surgical evaluation and management of a 63-year-old woman with recurrent ascites from liver cirrhosis who failed conservative therapy.
Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score
David Albala, MD, Michael J. Kemeter, MSPAS, Phillip G. Febbo, MD, Ruixiao Lu, PhD, Vincy John, Dylan Stoy, Bela Denes, MD, Marybeth McCall, MD, Alan W. Shindel, MD, Frank Dubeck, MD
This analysis compares management patterns and costs from a baseline, untested population to a similar prospective, Genomic Prostate Score (GPS)-tested population. This unique study design allowed the authors to assess both the clinical utility and economic impact of using GPS in a real-world setting.
Perioperative Considerations in Metastatic Renal Cell Carcinoma
Kate Flavin, MRCP, FRCA, FFICM, Nikhil Vasdev, Jim Ashead, Tim Lane, Damian Hanbury, Paul Nathan, Shanmugasundaram Gowrie-Mohan
Patients with metastatic renal cell carcinoma are complex, with the potential for significant complications, and require extensive pre-, peri-, and postoperative management. This article discusses, in depth, the necessary considerations in the treatment of these patients.
Urology Group Compensation and Ancillary Service Models in an Era of Value-based Care
Neal D. Shore, MD, FACS, Dana Jacoby, MBA, MHS
Implementing new payment algorithms alongside comprehensive care coordination will assist urology groups in addressing the health economic cost and quality challenges that have been historically encountered with fee-for-service systems. Urology group leadership and stakeholders will need to adjust internal processes, methods of care coordination, cultural dependency, and organizational structures in order to create better systems of care and management. In response, ancillary services and patient throughput will need to evolve in order to adequately align quality measurement and reporting systems across provider footprints and patient populations.
Planning for Success
Celeste G. Kirschner, CAE
Georgia Urology, Atlanta, GA
Vahan Kassabian, MD, FACS, FRCS, Cynthia Masters, Jason Shelnutt, Chris Speaker, RT, CRLS
Laparoscopic Cystectomy Coding
Jonathan Rubenstein, MD
Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA
Best of the 2016 AUA Annual Meeting
J. Curtis Nickel, MD, FRCSC, Michael A. Gorin, MD, Alan W. Partin, MD, PhD, Stacy Loeb, MD, MSc, Ellen Shapiro, MD, FACS, FAAP, Michael B. Chancellor, MD, Dean Assimos, MD, Michael Brawer, MD, Benjamin M. Brucker, MD
A Novel Approach to Mesh Revision After Sacrocolpopexy
Melissa L. Dawson, DO, MS, Rebecca Rinko, DO, Nima M. Shah, MD, Kristene E. Whitmore, MD
Reported herein are two cases of women with defecatory dysfunction and pain after sacrocolpopexy who underwent mesh revision procedures performed with both urogynecologic and colorectal surgery.
A Case of Pelvic Organ Prolapse in the Setting of Cirrhotic Ascites
Nima M. Shah, MD, Natasha Ginzburg, MD, Kristene Whitmore, MD
The authors present the surgical evaluation and management of a 63-year-old woman with recurrent ascites from liver cirrhosis who failed conservative therapy.
Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score
David Albala, MD, Michael J. Kemeter, MSPAS, Phillip G. Febbo, MD, Ruixiao Lu, PhD, Vincy John, Dylan Stoy, Bela Denes, MD, Marybeth McCall, MD, Alan W. Shindel, MD, Frank Dubeck, MD
This analysis compares management patterns and costs from a baseline, untested population to a similar prospective, Genomic Prostate Score (GPS)-tested population. This unique study design allowed the authors to assess both the clinical utility and economic impact of using GPS in a real-world setting.
Perioperative Considerations in Metastatic Renal Cell Carcinoma
Kate Flavin, MRCP, FRCA, FFICM, Nikhil Vasdev, Jim Ashead, Tim Lane, Damian Hanbury, Paul Nathan, Shanmugasundaram Gowrie-Mohan
Patients with metastatic renal cell carcinoma are complex, with the potential for significant complications, and require extensive pre-, peri-, and postoperative management. This article discusses, in depth, the necessary considerations in the treatment of these patients.
Urology Group Compensation and Ancillary Service Models in an Era of Value-based Care
Neal D. Shore, MD, FACS, Dana Jacoby, MBA, MHS
Implementing new payment algorithms alongside comprehensive care coordination will assist urology groups in addressing the health economic cost and quality challenges that have been historically encountered with fee-for-service systems. Urology group leadership and stakeholders will need to adjust internal processes, methods of care coordination, cultural dependency, and organizational structures in order to create better systems of care and management. In response, ancillary services and patient throughput will need to evolve in order to adequately align quality measurement and reporting systems across provider footprints and patient populations.
Planning for Success
Celeste G. Kirschner, CAE
Georgia Urology, Atlanta, GA
Vahan Kassabian, MD, FACS, FRCS, Cynthia Masters, Jason Shelnutt, Chris Speaker, RT, CRLS
Laparoscopic Cystectomy Coding
Jonathan Rubenstein, MD
Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA
Best of the 2016 AUA Annual Meeting
J. Curtis Nickel, MD, FRCSC, Michael A. Gorin, MD, Alan W. Partin, MD, PhD, Stacy Loeb, MD, MSc, Ellen Shapiro, MD, FACS, FAAP, Michael B. Chancellor, MD, Dean Assimos, MD, Michael Brawer, MD, Benjamin M. Brucker, MD
A Novel Approach to Mesh Revision After Sacrocolpopexy
Melissa L. Dawson, DO, MS, Rebecca Rinko, DO, Nima M. Shah, MD, Kristene E. Whitmore, MD
Reported herein are two cases of women with defecatory dysfunction and pain after sacrocolpopexy who underwent mesh revision procedures performed with both urogynecologic and colorectal surgery.
A Case of Pelvic Organ Prolapse in the Setting of Cirrhotic Ascites
Nima M. Shah, MD, Natasha Ginzburg, MD, Kristene Whitmore, MD
The authors present the surgical evaluation and management of a 63-year-old woman with recurrent ascites from liver cirrhosis who failed conservative therapy.